List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 395 studies with search of: "Amgen" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: anakinra;   Drug: pegsunercept
2 Terminated A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy
Conditions: Anemia;   Cancer
Intervention: Drug: AMG 114
3 Active, not recruiting Phase 1b Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Breast Cancer
Condition: Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Paclitaxel;   Drug: AMG 706
4 Recruiting Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
Condition: Psoriasis
Intervention: Drug: AMG 827
5 Completed Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis
Condition: Kidney Disease
Intervention: Drug: Aranesp®
6 Completed A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
Condition: Nephrology
Intervention: Drug: Sensipar®
7 Completed STAAR-2 Clinical Study
Conditions: Chronic Kidney Disease;   Chronic Renal Insufficiency;   Kidney Disease;   Pre-Dialysis;   Pre-ESRD
Intervention: Drug: darbepoetin alfa
8 Recruiting An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer
Conditions: Cancer;   Carcinoma;   Castrate-Resistant Prostate Cancer;   Prostate Cancer;   Tumors
Intervention: Drug: Denosumab
9 Completed Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: epratuzumab
10 Completed Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease
Conditions: Anemia;   Kidney Disease
Intervention: Drug: Darbepoetin Alfa
11 Completed Post Transplant Study
Conditions: Kidney Tansplant;   Secondary Hyperparathyroidism;   Hyperparathyroidism
Intervention: Drug: Sensipar after Post Transplant
12 Completed Treatment for Subjects With Active Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Intervention: Drug: Etanercept Liquid
13 Active, not recruiting Open-Label Extension Treatment With TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trials
Condition: Rheumatoid Arthritis
Intervention: Biological: Etanercept
14 Active, not recruiting Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: AMG 531;   Drug: Placebo
15 Completed Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis
Condition: End Stage Renal Disease
Intervention: Drug: Aranesp®
16 Completed ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Sensipar®
17 Completed Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
Conditions: Colorectal Cancer;   Non-Small Cell Lung Cancer;   Prostate Cancer;   Solid Tumors;   Advanced Renal Cell Carcinoma
Intervention: Drug: Panitumumab (ABX-EGF)
18 Active, not recruiting Panitumumab Plus FOLFIRI in First-Line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: panitumumab and FOLFIRI
19 Active, not recruiting Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
Conditions: Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma;   Sarcoma;   Soft Tissue Sarcoma
Interventions: Drug: AMG 655;   Other: Placebo
20 Completed Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy
Conditions: Neoplasms;   Anemia
Intervention: Drug: darbepoetin alfa

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services